Related Experiment Video
Updated: Dec 9, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Platelets and renal failure in the SARS-CoV-2 syndrome
Muhanad Taha1, Dahlia Sano2, Samer Hanoudi3
1Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University, School of Medicine and Detroit Medical Center , Detroit, MI, USA.
Activated platelets may contribute to kidney injury and hypercoagulability in critically ill patients with COVID-19. This study found high rates of acute kidney injury (AKI) and unique platelet characteristics in these patients.
Area of Science:
- Nephrology
- Hematology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, involves systemic complications beyond respiratory failure.
- The mechanisms of acute kidney injury (AKI) and hypercoagulable states in COVID-19 are not fully understood.
- SARS-CoV-2 entry into human cells involves the ACE2 receptor, and its cleavage impacts angiotensin II levels and platelet function.
Purpose of the Study:
- To investigate the incidence of AKI in critically ill COVID-19 patients.
- To examine platelet characteristics and their correlation with renal function and coagulation markers.
- To explore the potential role of platelets in COVID-19-associated renal failure and hypercoagulability.
Main Methods:
- Retrospective analysis of critically ill adult COVID-19 patients.
- Measurement of laboratory markers including D-dimer, ferritin, CRP, LDH, and MPV.
- Assessment of glomerular filtration rates (GFR).
Main Results:
- High incidence of AKI (81%) observed in critically ill COVID-19 patients.
- Elevated D-dimer, ferritin, CRP, and LDH levels were common.
- Patients exhibited unique platelet features: larger, more granular platelets with higher MPV.
- Significant correlation found between D-dimer and MPV; negative correlation between MPV and GFR.
Conclusions:
- Activated platelets may play a significant role in the pathogenesis of AKI in COVID-19.
- Platelet activation and altered characteristics could contribute to the hypercoagulable state observed in COVID-19 patients.
- Further research is warranted to elucidate the precise mechanisms linking platelets, renal function, and coagulation in COVID-19.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Acute Kidney Injury II: Pathophysiology
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Nephrotic Syndrome I : Introduction
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...

